This inventor holds 13 USPTO granted patents and 1 published patent application, primarily in Adenoviral Vectors. Top assignees: Calydon, Inc., Cell Genesys, Inc., Other. Active years: 1997-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cupertino, CA (US) (1997 - 2000)
- Palo Alto, CA (US) (2001 - 2008)
Company Filing History:
6 out of 10 
6 out of 78 
1 out of 834,708 Years Active: 1997-2008
Areas of Expertise:
Title: The Innovations of Eric R. Schuur: Pioneering Adenoviral Vector Research
Introduction: Eric R. Schuur, based in Palo Alto, California, is a prominent inventor known for his contributions to the field of biomedical engineering, particularly in adenoviral vector technology. With a remarkable portfolio of 13 patents, Schuur has been at the forefront of innovations aimed at advancing gene therapy and targeted cancer treatments.
Latest Patents: Among his latest patents, Schuur developed adenovirus vectors specific for cells expressing the androgen receptor. This invention outlines replication-competent adenovirus vectors designed to target cells that allow a probasin transcriptional response element to function. The designed viruses can incorporate adenoviral genes controlled by transcriptional regulatory elements, contributing significantly to viral replication specifically in prostate carcinoma cells. Furthermore, he has also contributed to the development of adenoviral vectors specific for cells expressing alpha-fetoprotein (AFP). These vectors, essential for replication, are controlled by an AFP-transcriptional regulatory element, further enriching the arsenal of tools available for targeted cancer therapies.
Career Highlights: Throughout his career, Eric R. Schuur has been instrumental in pushing the boundaries of biomedical innovation. His time at notable companies like Cell Genesys, Inc. and Calydon, Inc. has provided him with unique opportunities to refine his research and collaborate with other leading experts in the field.
Collaborations: Schuur has worked alongside esteemed colleagues such as Daniel R. Henderson and Henry G. Lamparski. These collaborations have been essential in the development and application of his patented technologies, fostering an environment that promotes groundbreaking research in gene therapy.
Conclusion: Eric R. Schuur stands as a prominent figure in the realm of innovative medical research. His advancements, particularly in adenoviral vector technology, mark significant strides toward effective treatments for complex diseases such as cancer. With numerous patents to his name, Schuur continues to influence future innovations in biomedical engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile